Pulmonary Fibrosis
|
0.510 |
Biomarker
|
disease |
RGD |
Herein we have studied, using RT-competitive PCR, the expression of GM-CSF mRNA during the early steps of pulmonary fibrosis development after intra-alveolar instillation of bleomycin, a well-established experimental model of this lesion.
|
9881949 |
1998 |
Parkinsonian Disorders
|
0.240 |
Biomarker
|
group |
RGD |
Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease.
|
21291297 |
2011 |
Myocardial Infarction
|
0.230 |
Biomarker
|
disease |
RGD |
Antibody to granulocyte macrophage colony-stimulating factor reduces the number of activated tissue macrophages and improves left ventricular function after myocardial infarction in a rat coronary artery ligation model.
|
21326109 |
2011 |
Aortic Aneurysm, Abdominal
|
0.210 |
ModifyingMutation
|
disease |
RGD |
Hemodynamic forces regulate mural macrophage infiltration in experimental aortic aneurysms.
|
15010288 |
2004 |
Pneumocystis jiroveci pneumonia
|
0.210 |
Biomarker
|
disease |
RGD |
Effects of decreased calmodulin protein on the survival mechanisms of alveolar macrophages during Pneumocystis pneumonia.
|
19487471 |
2009 |
Bronchiolitis Obliterans
|
0.200 |
Biomarker
|
disease |
RGD |
Chronic aspiration of gastric fluid induces the development of obliterative bronchiolitis in rat lung transplants.
|
18557728 |
2008 |
Silicosis
|
0.200 |
Biomarker
|
disease |
RGD |
Cross-talk of the related bioactivity mediators in serum after injection of soluble TNF-α receptor on silicosis model of rats.
|
21505002 |
2011 |
Interstitial Cystitis
|
0.200 |
Biomarker
|
disease |
RGD |
Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitis.
|
18848347 |
2009 |
Schizophrenia
|
0.350 |
Biomarker
|
disease |
PSYGENET |
We report results of a case-control WGA study in schizophrenia, examining approximately 500 000 markers, which revealed a strong effect (P=3.7 x 10(-7)) of a novel locus (rs4129148) near the CSF2RA (colony stimulating factor, receptor 2 alpha) gene in the pseudoautosomal region.
|
17522711 |
2007 |
Pulmonary Alveolar Proteinosis
|
0.300 |
Biomarker
|
disease |
MGD |
Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.
|
8202532 |
1994 |
Pulmonary Alveolar Proteinosis
|
0.300 |
Biomarker
|
disease |
MGD |
Granulocyte-macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria.
|
11119498 |
2001 |
Pulmonary Alveolar Proteinosis
|
0.300 |
Biomarker
|
disease |
MGD |
Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis.
|
8171324 |
1994 |
Pulmonary Alveolar Proteinosis
|
0.300 |
Biomarker
|
disease |
MGD |
Characterization of ovarian function in granulocyte-macrophage colony-stimulating factor-deficient mice.
|
10684813 |
2000 |
Pulmonary Alveolar Proteinosis
|
0.300 |
Biomarker
|
disease |
MGD |
Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease.
|
19196868 |
2009 |
Pulmonary Alveolar Proteinosis
|
0.300 |
Biomarker
|
disease |
MGD |
Fertility impairment in granulocyte-macrophage colony-stimulating factor-deficient mice.
|
9915988 |
1999 |
Leukemia, Myelocytic, Acute
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
In vitro studies demonstrated that leptin increased AML blast release of interleukin (IL) 1beta, IL6, tumor necrosis factor (TNF) alpha and granulocyte-macrophage colony-stimulating factor (GM-CSF).
|
12031914 |
2002 |
Inflammation
|
0.310 |
Biomarker
|
phenotype |
LHGDN |
This review summarizes the evidence supporting a major role for GM-CSF in inflammation and autoimmunity and its functions as major regulator governing granulocyte and macrophage lineage populations at all stages of maturation.
|
16167889 |
2005 |
Lymphoma, Non-Hodgkin
|
0.310 |
AlteredExpression
|
disease |
LHGDN |
Induction of apoptosis and bcl-2 expression in acute lymphoblastic leukaemia and non-Hodgkin's lymphoma in children.
|
11855781 |
2001 |
Pulmonary Alveolar Proteinosis
|
0.300 |
Biomarker
|
disease |
LHGDN |
Elevated IL-10 inhibits GM-CSF synthesis in pulmonary alveolar proteinosis.
|
14567558 |
2003 |
Pulmonary Alveolar Proteinosis
|
0.300 |
Biomarker
|
disease |
LHGDN |
High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.
|
14512323 |
2004 |
leukemia
|
0.100 |
AlteredExpression
|
disease |
LHGDN |
GM-CSF does not increase CD20 antigen expression on chronic lymphocytic leukemia lymphocytes.
|
15927668 |
2005 |
Dermatitis, Atopic
|
0.070 |
GeneticVariation
|
disease |
LHGDN |
The GM-CSF genotype is an important genetic marker predicting an individual's predisposition to atopic dermatitis.
|
13679820 |
2003 |
Chronic Obstructive Airway Disease
|
0.070 |
GeneticVariation
|
disease |
LHGDN |
This study suggests that polymorphisms in both CSF2 and IL8 may play a role in the pathogenesis of COPD, at least in highly exposed populations.
|
17681858 |
2008 |
Squamous cell carcinoma
|
0.050 |
Biomarker
|
disease |
LHGDN |
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.
|
16912178 |
2006 |
Acute monocytic leukemia
|
0.040 |
AlteredExpression
|
disease |
LHGDN |
Contribution of GM-CSF and IL-8 to the CD44-induced differentiation of acute monoblastic leukemia.
|
17914409 |
2008 |